Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Cancer

Volumn 80, Issue 11, 1997, Pages 2060-2067

  Shiratori, Yasushi ^a,b   Shiina, Shuichiro ^a   Zhang, Pei Yi ^a   Ohno, Etsu ^a   Okudaira, Takehito ^a   Payawal, Diana A ^a   Ono Nita, Suzane K ^a   Imamura, Masatoshi ^a   Kato, Naoya ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Clinicopathologic features; Dual infection; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Mutually exclusive viral replication

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS REPLICATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE;

EID: 0030679580     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971201)80:11<2060::AID-CNCR4>3.0.CO;2-0     Document Type: Article

References (48)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;ii:1004-6.
3. Hasan F, Jeffers LJ, Medina MD, Reddy KR, Parker T, Schiff ER, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990;12:589-91.
4. Farinati F, Fagiuoli S, Maria ND, Chiaramonte M, Aneloni V, Ongaro S, et al. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features. J Hepatol 1992;14:183-7.
5. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-41.
6. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Watanabe Y, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-9.
7. Ohkoshi S, Kojima H, Tawaraya H, Miyajima T, Kamimura T, Asakura H, et al. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J Cancer Res 1990;81:550-3.
8. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-7,
9. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factor for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
10. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47: 4967-72.
11. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-63.
12. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;22:1027-33.
13. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Hepatology 1982;2:s21-6.
14. Shafritz D, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integrations of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 1981;305:1067-73.
15. Brechot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, et al. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver disease. Proc Natl Acad Sci USA 1981;78:3906-10.
16. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80-5.
17. Hino O, Kitagawa T, Sugano H. Relationship between serum and histochemical markers for hepatitis B virus and rate of viral integration in hepatocellular carcinoma in Japan [in Japanese]. J Cancer 1985;35:5-10.
18. Sakamoto M, Hirohashi S, Tsuda H, Ino Y, Shimosato Y, Yamasaki S, et al. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, discovered by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res 1988;48:7294-7.
19. Sheu JG, Huang GT, Shih LN, Lee WC, Chou HC, Wang JT, et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103: 1322-7.
20. Lai MY, Chen PJ, Yang PM, Sheu JC, Sung JL, Chen DS. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology 1990;12:575-81.
21. Poynard T, Aubert A, Lazizi Y, Bedossa P, Hamelin B, Terris B, et al. Independent risk factor for hepatocellular carcinoma in French drinkers. Hepatology 1991;13:896-901.
22. Levrero M, Tagger A, Balsano C, De Marzio E, Avantaggiati ML, Natoli G, et al. Antibodies to hepatitis C virus in patients, with hepatocellular carcinoma. J Hepatol 1991;12:60-3.
23. Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A, et al. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1991;12:367-71.
24. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992;116:97-102.
25. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United State. J Natl Cancer Inst 1990;82:1038-41.
26. Naplas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C, et al. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991;12:70-4.
27. Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. Cancer 1992;69: 2052-4.
28. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;256:1974-6.
29. Hadziyannis SJ, Giannoulis G, Hadziyannis E, Kaklamani E, Alexopoulou A, Dourakis S, et al. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993;17(Suppl 3):S72-7.
30. Liang TJ, Jeffers LJ, Reddy KR, Medina MD, Parker IT, Cheinquer H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993;18:1326-33.
31. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient with hepatitis B virus serologic markers. Hepatology 1990; 12:204-12.
32. Child CG, Turcott JG. Surgery in portal hypertension. In: Child CG, editor. Major problems in clinical surgery: the liver and portal hypertension. Philadelphia: W. B. Saunders, 1964:1-85.
33. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection. Hepatology 1990;13:627-31.
34. Kato N, Yokosuka O, Omata M, Hosoda K, Ohto M. Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J Clin Invest 1990; 86:1764-7.
35. Okamoto H, Kurai K, Okada SI, Mayumi M. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992;188:331-41.
36. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Sheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
37. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35:828-32.
38. Fong TL, Bisceglie AD, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991;14:64-7.
39. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infection. Gastroenterology 1993;105:1529-33.
40. Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994;106:1048-53.
41. Koike K, Yasuda K, Yotsuyanagi H, Moriya K, Hino K, Kurokawa K, et al. Dominant replication of either virus in dual infection with hepatitis B and C. J Med Virol 1995;45:236-9.
42. Tsai SL, Liaw YF, Yeh CT, Chu CM, Kuo G. Cellular immune responses in patients with dual infections of hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology 1995;21:908-12.
43. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995;22:1101-8.
44. Ikeda K, Saito S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
45. Krugman S, Hoofnagle JH, Gerety RJ, Kaplan PM, Gerin JL. Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med 1974;290: 1331-5.
46. Omata M, Afroudakis A, Liew CT, Ashcavai M, Peters RL. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg). Gastroenterology 1978;75:1003-9.
47. Kojima M, Uda K, Takahashi Y, Yoshizawa H, Tsuda F, Itoh Y, et al. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigen in the liver. Gastroenterology 1977;73:664-7.
48. Lok ASF, Ma OCK, Chan TM. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology 1991;14:756-62.